E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT.
Open accessThe DOI matches its Crossref record; 65 of the 67 references it cites were found in a registry or an index.
Abstract
Background: Over the past few years, a large number of smokers in the UK have stopped smoking with the help of e-cigarettes. So far, UK Stop Smoking Services (SSSs) have been reluctant to include e-cigarettes among their treatment options because data on their efficacy compared with the licensed medications are lacking. Objective: The objective was to compare the efficacy of refillable e-cigarettes and nicotine replacement therapy (NRT) products, when accompanied by weekly behavioural support. Design: A randomised controlled trial comparing e-cigarettes and NRT. Setting: Three sites that provide local SSSs. Participants: The participants were 886 smokers seeking help to quit smoking, aged ≥ 18 years, not pregnant or breastfeeding, with no strong preference to use or not to use NRT or e-cigarettes in their quit attempt, and currently not using NRT or e-cigarettes. A total of 886 participants were randomised but two died during the study (one in each study arm) and were not included in the analysis. Interventions: The NRT arm ( n = 446) received NRT of their choice (single or combination), provided for up to 12 weeks. The e-cigarette arm ( n = 438) received an e-cigarette starter pack and were encouraged to buy addtional e-liquids and e-cigarette products of their choice. Both arms received the same standard behavioural support. Participants attended weekly sessions at their SSS and provided outcome data at 4 weeks. They were then followed up by telephone at 6 and 12 months. Participants reporting abstinence or at least 50% reduction in cigarette consumption at 12 months were invited to attend for carbon monoxide (CO) validation. Participants/researchers could not be blinded to the intervention. Main outcome measures: The primary outcome was CO-validated sustained abstinence rates at 52 weeks. Participants lost to follow-up or not providing biochemical validation were included as non-abstainers. Secondary outcomes included abstinence at other time points, reduction in smoke intake, treatment adherence and ratings, elicited adverse reactions, and changes in self-reported respiratory health. A cost-efficacy analysis of the intervention was also conducted. Results: The 1-year quit rate was 9.9% in the NRT arm and 18.0% in the e-cigarette arm (risk ratio 1.83, 95% confidence interval 1.30 to 2.58; p < 0.001). The e-cigarette arm had significantly higher validated quit rates at all time points. Participants in the e-cigarette arm showed significantly better adherence and experienced fewer urges to smoke throughout the initial 4 weeks of their quit attempt than those in the NRT arm, and gave their allocated product more favourable ratings. They were also more likely to be still using their allocated product at 1 year (39.5% vs. 4.3%, χ 2 = 161.4; p < 0.001). Participants assigned to e-cigarettes reported significantly less coughing and phlegm at 1 year than those assigned to NRT (controlling for smoking status). A detailed economic analysis confirmed that, because e-cigarettes incur lower NHS costs than NRT and generate a higher quit rate, e-cigarette use is more cost-effective. Limitations: The results may not be generalisable to other types of smokers or settings, or to cartridge-based e-cigarettes. Conclusions: Within the context of multisession treatment for smokers seeking help, e-cigarettes were significantly more effective than NRT. If SSSs provide e-cigarette starter packs, it is likely to boost their success rates and improve their cost-efficacy. Future work: The efficacy of e-cigarettes provided with different levels of support will show whether smokers should be encouraged to switch to vaping within support services or whether e-cigarettes can be recommended with less intensive or no support. Trial registration: Current Controlled Trials ISRCTN60477608. Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment ; Vol. 23, No. 43. See the NIHR Journals Library website for further project information. The trial was supported by the Cancer Research UK Prevention Trials Unit (grant A16893).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nine trials reported on the potential short-term harms of electronic cigarette use for cessation; none suggested relatively higher rates of serious AEs.[76](#R76)-[80](#R80),[82](#R82),[86](#R86),[87](#R87),[89](#R89)”
From Interventions for Tobacco Cessation in Adults, Including Pregnant Persons (2021) · cites this paper as [86]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Five trials (N=3,117) were included that evaluated the effectiveness of using e-cigarettes to help current conventional smokers stop or reduce smoking compared with placebo or nicotine replacement therapy ([eTable 3](#SD1)).[76](#R76),[77](#R77),[86](#R86),[87](#R87),[89](#R89)”
From Interventions for Tobacco Cessation in Adults, Including Pregnant Persons (2021) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Multiple imputation using chained equations: Issues and guidance for practice
White, I. R., Royston, P., & Wood, A. M. (2011) · Statistics in Medicine · doi:10.1002/sim.4067 · Cited by 9,792
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 5,932
The Health consequences of smoking—50 years of progress : a report of the Surgeon General
Lushniak, B. D., Samet, J. M., Pechacek, T. F., Norman, L., & Taylor, P. A. (2014) · Cited by 4,990
Decision Modelling For Health Economic Evaluation
Briggs, A., Claxton, K., & Sculpher, M. (2006) · doi:10.1093/oso/9780198526629.001.0001 · Cited by 3,153
Mortality in relation to smoking: 50 years' observations on male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920 · cited 2×
“Resource Trial arm, mean (SE) (£) NRT (n= 447) E-cigarette (n= 439) Mean cost in the 6 months before baseline Smoking cessation help cost 9 (1) 8 (1) Pharmacotherapy cost 24 (7) 20 (7) Health-care service use cost 612 (108) 512 (62) Cost to the NHS 645 (109) 539 (62) Mean cost in the 6 months post TQD Smoking cessatio…”
BackgroundInternational Agency for Research on Cancer (IARC)
(2018) · The Grants Register 2018 · doi:10.1007/978-1-349-94186-5_629 · Cited by 2,801
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,464 · cited 3×
“Variable Missing values, n (%) Age 0 (0) Sex 0 (0) Trial site 0 (0) Entitlement to free prescriptions 0 (0) Ethnicity 0 (0) Intervention cost Training 0 (0) Delivery 0 (0) Baseline FTCD 0 (0) Smoking cessation help cost Baseline 0 (0) 6 months 307 (35) 12 months 285 (32) Pharmacotherapies prescription cost Baseline 0…”
BackgroundInterim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets
van Hout, B., Janssen, M. F., Feng, Y.-S., Kohlmann, T., Busschbach, J., Golicki, D., Lloyd, A., Scalone, L., Kind, P., & Pickard, A. S. (2012) · Value in Health · doi:10.1016/j.jval.2012.02.008 · Cited by 2,153
Guidelines for authors and peer reviewers of economic submissions to the BMJ
Drummond, M. F., & Jefferson, T. O. (1996) · BMJ · doi:10.1136/bmj.313.7052.275 · Cited by 1,827 · cited 1×
“5) Inhalator 163 (37) Mouth spray 124 (28) Selecting two NRT products 393 (88) Switched to different NRT product in first 4 weeks 260 (59) a Information is missing for four participants.”
BackgroundA Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy
Hajek, P., Phillips-Waller, A., Przulj, D., Pesola, F., Myers Smith, K., Bisal, N., Li, J., Parrott, S., Sasieni, P., Dawkins, L., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1808779 · Cited by 1,421 · cited 4×
“Costs, QALYs and ICER Trial arm NRT (n= 447) E-cigarette (n= 439) Costs during the trial period (£) Intervention cost (SE) 201 (4) 105 (1) Smoking cessation costs (SE) 77 (13) 48 (11) Health-care costs (SE) 839 (162) 1022 (147) Total costs during the trial period (SE) 1116 (163) 1174 (147) Difference in total costs du…”
BackgroundInfluentialSelf-citationOutcome criteria in smoking cessation trials: proposal for a common standard
West, R., Hajek, P., Stead, L., & Stapleton, J. (2005) · Addiction · doi:10.1111/j.1360-0443.2004.00995.x · Cited by 1,285
Anthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., Ascher, J., Russ, C., Krishen, A., & Evins, A. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30272-0 · Cited by 1,177
Representing uncertainty: the role of cost‐effectiveness acceptability curves
Fenwick, E., Claxton, K., & Sculpher, M. (2001) · Health Economics · doi:10.1002/hec.635 · Cited by 1,110
Electronic cigarettes for smoking cessation: a randomised controlled trial.
Bullen, C., Howe, C., Laugesen, M., McRobbie, H., Parag, V., Williman, J., & Walker, N. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61842-5 · Cited by 1,094 · cited 2×
“Level EQ-5D-5L dimension, n (%) Mobility Self-care Usual activities Pain/discomfort Anxiety/depression NRT E-cigarette NRT E-cigarette NRT E-cigarette NRT E-cigarette NRT E-cigarette Baseline (NRT arm, n = 447; e-cigarette arm, n = 439) 1 389 (87) 369 (84) 428 (96) 415 (95) 388 (87) 380 (87) 313 (70) 302 (69) 316 (71)…”
BackgroundSelf-citationElectronic cigarettes for smoking cessation
Hartmann-Boyce, J., McRobbie, H., Bullen, C., Begh, R., Stead, L. F., & Hajek, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub3 · Cited by 1,002
Self-citationDeterminants of Tobacco Use and Renaming the FTND to the Fagerstrom Test for Cigarette Dependence
Fagerstrom, K. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr137 · Cited by 976 · cited 2×
“Level EQ-5D-5L dimension, n (%) Mobility Self-care Usual activities Pain/discomfort Anxiety/depression NRT E-cigarette NRT E-cigarette NRT E-cigarette NRT E-cigarette NRT E-cigarette Baseline (NRT arm, n = 447; e-cigarette arm, n = 439) 1 389 (87) 369 (84) 428 (96) 415 (95) 388 (87) 380 (87) 313 (70) 302 (69) 316 (71)…”
Combined pharmacotherapy and behavioural interventions for smoking cessation
Stead, L. F., Koilpillai, P., Fanshawe, T. R., & Lancaster, T. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008286.pub3 · Cited by 829
Caponnetto, P., Campagna, D., Cibella, F., Morjaria, J. B., Caruso, M., Russo, C., & Polosa, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066317 · Cited by 711 · cited 3×
“Level EQ-5D-5L dimension, n (%) Mobility Self-care Usual activities Pain/discomfort Anxiety/depression NRT E-cigarette NRT E-cigarette NRT E-cigarette NRT E-cigarette NRT E-cigarette Baseline (NRT arm, n = 447; e-cigarette arm, n = 439) 1 389 (87) 369 (84) 428 (96) 415 (95) 388 (87) 380 (87) 313 (70) 302 (69) 316 (71)…”
BackgroundStatistical Matching Using File Concatenation With Adjusted Weights and Multiple Imputations
Rubin, D. B. (1986) · Journal of Business & Economic Statistics · doi:10.1080/07350015.1986.10509497 · Cited by 551
Hajek, P., Etter, J., Benowitz, N., Eissenberg, T., & McRobbie, H. (2014) · Addiction · doi:10.1111/add.12659 · Cited by 546
Self-citationShahab, L., Goniewicz, M. L., Blount, B. C., Brown, J., McNeill, A., Alwis, K. U., Feng, J., Wang, L., & West, R. (2017) · Annals of Internal Medicine · doi:10.7326/m16-1107 · Cited by 538 · cited 1×
“AR Trial arm, n (%) Relative risk (95% CI) E-cigarette (N= 438) NRT (N= 446) Nausea 137 (31) 169 (38) 0.”
Self-citation‘Vaping’ profiles and preferences: an online survey of electronic cigarette users
Dawkins, L., Turner, J., Roberts, A., & Soar, K. (2013) · Addiction · doi:10.1111/add.12150 · Cited by 461
Self-citationFoulds, J., Veldheer, S., Yingst, J., Hrabovsky, S., Wilson, S. J., Nichols, T. T., & Eissenberg, T. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntu204 · Cited by 460 · cited 1×
“Flavour Week, n (%) 1 (N= 155) 4 (N= 156) 26 (N= 516) 52 (N= 511) Tobacco 15 (10) 44 (28) 163 (32) 127 (25) Fruit 70 (45) 51 (33) 150 (30) 169 (33) Menthol/mint 31 (20) 20 (13) 75 (15) 81 (16) Tobacco menthol 5 (3.”
Farsalinos, K. E., Spyrou, A., Tsimopoulou, K., Stefopoulos, C., Romagna, G., & Voudris, V. (2014) · Scientific Reports · doi:10.1038/srep04133 · Cited by 435
Sussan, T. E., Gajghate, S., Thimmulappa, R. K., Ma, J., Kim, J.-H., Sudini, K., Consolini, N., Cormier, S. A., Lomnicki, S., Hasan, F., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116861 · Cited by 429
The English smoking treatment services: one‐year outcomes
Ferguson, J., Bauld, L., Chesterman, J., & Judge, K. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01028.x · Cited by 347 · cited 1×
“Flavour Week, n (%) 1 (N= 155) 4 (N= 156) 26 (N= 516) 52 (N= 511) Tobacco 15 (10) 44 (28) 163 (32) 127 (25) Fruit 70 (45) 51 (33) 150 (30) 169 (33) Menthol/mint 31 (20) 20 (13) 75 (15) 81 (16) Tobacco menthol 5 (3.”
Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting
Petrou, S., & Gray, A. (2011) · BMJ · doi:10.1136/bmj.d1548 · Cited by 318 · cited 1×
“Resource Trial arm, mean (SE) (£) NRT (n= 447) E-cigarette (n= 439) Mean cost in the 6 months before baseline Smoking cessation help cost 9 (1) 8 (1) Pharmacotherapy cost 24 (7) 20 (7) Health-care service use cost 612 (108) 512 (62) Cost to the NHS 645 (109) 539 (62) Mean cost in the 6 months post TQD Smoking cessatio…”
BackgroundESTIMATING CONFIDENCE INTERVALS FOR COST-EFFECTIVENESS RATIOS: AN EXAMPLE FROM A RANDOMIZED TRIAL
CHAUDHARY, M. A., & STEARNS, S. C. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19960715)15:13<1447::aid-sim267>3.0.co;2-v · Cited by 313 · cited 1×
“Trial arm NRT E-cigarette Baseline 6 months 12 months Baseline 6 months 12 months Cost of smoking cessation help Number of responders 447 271 286 439 308 315 Mean cost (SD) (£) 9 (25) 6 (22) 14 (55) 8 (29) 5 (33) 6 (28) Cost of NRT products Number of responders 447 267 283 439 306 316 On prescription, mean cost (SD) (…”
Fenwick, E., Marshall, D. A., Levy, A. R., & Nichol, G. (2006) · BMC Health Services Research · doi:10.1186/1472-6963-6-52 · Cited by 279
Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal
West, R., & Hajek, P. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1923-6 · Cited by 257 · cited 2×
“Level EQ-5D-5L dimension, n (%) Mobility Self-care Usual activities Pain/discomfort Anxiety/depression NRT E-cigarette NRT E-cigarette NRT E-cigarette NRT E-cigarette NRT E-cigarette Baseline (NRT arm, n = 447; e-cigarette arm, n = 439) 1 389 (87) 369 (84) 428 (96) 415 (95) 388 (87) 380 (87) 313 (70) 302 (69) 316 (71)…”
Richardson, G., & Manca, A. (2004) · Health Economics · doi:10.1002/hec.901 · Cited by 250
Wu, Q., Jiang, D., Minor, M., & Chu, H. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108342 · Cited by 243 · cited 1×
“Variable Missing values, n (%) Age 0 (0) Sex 0 (0) Trial site 0 (0) Entitlement to free prescriptions 0 (0) Ethnicity 0 (0) Intervention cost Training 0 (0) Delivery 0 (0) Baseline FTCD 0 (0) Smoking cessation help cost Baseline 0 (0) 6 months 307 (35) 12 months 285 (32) Pharmacotherapies prescription cost Baseline 0…”
BackgroundSelf-citationAdriaens, K., Van Gucht, D., Declerck, P., & Baeyens, F. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph111111220 · Cited by 224 · cited 4×
“Costs, QALYs and ICER Trial arm NRT (n= 447) E-cigarette (n= 439) Costs during the trial period (£) Intervention cost (SE) 201 (4) 105 (1) Smoking cessation costs (SE) 77 (13) 48 (11) Health-care costs (SE) 839 (162) 1022 (147) Total costs during the trial period (SE) 1116 (163) 1174 (147) Difference in total costs du…”
BackgroundInfluentialBlondal, T., Gudmundsson, L. J., Olafsdottir, I., Gustavsson, G., Westin, A., & Stapleton, J. (1999) · BMJ · doi:10.1136/bmj.318.7179.285 · Cited by 219
Confidence intervals for cost-effectiveness ratios: An application of Fieller's theorem
Willan, A. R., & OʼBrien, B. J. (1996) · Health Economics · doi:10.1002/(sici)1099-1050(199607)5:4<297::aid-hec216>3.0.co;2-t · Cited by 218
A Pragmatic Trial of E-Cigarettes, Incentives, and Drugs for Smoking Cessation
Halpern, S. D., Harhay, M. O., Saulsgiver, K., Brophy, C., Troxel, A. B., & Volpp, K. G. (2018) · New England Journal of Medicine · doi:10.1056/nejmsa1715757 · Cited by 208 · cited 5×
“Cost of varenicline Number of responders 447 272 286 439 306 317 Mean cost (SD) (£) 4 (24) 2 (12) 4 (25) 2 (17) 1 (15) 3 (19) DOI: 10.”
InfluentialRelapse to smoking after 1 year of abstinence: A meta-analysis
Hughes, J. R., Peters, E. N., & Naud, S. (2008) · Addictive Behaviors · doi:10.1016/j.addbeh.2008.05.012 · Cited by 202 · cited 2×
“99) Sleep disturbances 279 (64) 303 (68) 0.”
Vogl, M., Wenig, C. M., Leidl, R., & Pokhrel, S. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-203 · Cited by 163
Nicotine delivery to users from cigarettes and from different types of e-cigarettes
Hajek, P., Przulj, D., Phillips, A., Anderson, R., & McRobbie, H. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4512-6 · Cited by 151
Self-citationNicotine Intake From Electronic Cigarettes on Initial Use and After 4 Weeks of Regular Use
Hajek, P., Goniewicz, M. L., Phillips, A., Myers Smith, K., West, O., & McRobbie, H. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntu153 · Cited by 109 · cited 2×
“Variable Missing values, n (%) Age 0 (0) Sex 0 (0) Trial site 0 (0) Entitlement to free prescriptions 0 (0) Ethnicity 0 (0) Intervention cost Training 0 (0) Delivery 0 (0) Baseline FTCD 0 (0) Smoking cessation help cost Baseline 0 (0) 6 months 307 (35) 12 months 285 (32) Pharmacotherapies prescription cost Baseline 0…”
BackgroundSelf-citationCigarette smoking prevalence, cessation and relapse
Stapleton, J. (1998) · Statistical Methods in Medical Research · doi:10.1177/096228029800700206 · Cited by 103 · cited 1×
“Cost of varenicline Number of responders 447 272 286 439 306 317 Mean cost (SD) (£) 4 (24) 2 (12) 4 (25) 2 (17) 1 (15) 3 (19) DOI: 10.”
Withdrawal‐oriented Therapy for Smokers
HAJEK, P. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb03474.x · Cited by 103 · cited 1×
“7) Chocolate, dessert, candy or sweet 17 (11) 18 (12) 62 (12) 72 (14) No flavour 0 (0) 0 (0) 0 (0) 2 (0.”
Long-Term Smoking Relapse: A Study Using the British Household Panel Survey
Hawkins, J. E., Hollingworth, W., & Campbell, R. M. (2010) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq175 · Cited by 102 · cited 1×
“Level EQ-5D-5L dimension, n (%) Mobility Self-care Usual activities Pain/discomfort Anxiety/depression NRT E-cigarette NRT E-cigarette NRT E-cigarette NRT E-cigarette NRT E-cigarette Baseline (NRT arm, n = 447; e-cigarette arm, n = 439) 1 389 (87) 369 (84) 428 (96) 415 (95) 388 (87) 380 (87) 313 (70) 302 (69) 316 (71)…”
Polosa, R., Caponnetto, P., Maglia, M., Morjaria, J. B., & Russo, C. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-1159 · Cited by 100
Long-term use of nicotine chewing gum. Occurrence, determinants, and effect on weight gain
Hajek, P. (1988) · JAMA · doi:10.1001/jama.260.11.1593 · Cited by 97
Household characteristics affecting where mothers deliver in rural Kenya
Hodgkin, D. (1996) · Health Economics · doi:10.1002/(sici)1099-1050(199607)5:4<279::aid-hec218>3.0.co;2-j · Cited by 89
Dawkins, L., Kimber, C., Puwanesarasa, Y., & Soar, K. (2015) · Addiction · doi:10.1111/add.12807 · Cited by 85
Self-citationMcEwen, A., Hájek, P., McRobbie, H. J., & West, R. (2006) · Wiley eBooks · doi:10.1002/9780470757864 · Cited by 76
Self-citationStapleton, J., West, R., Hajek, P., Wheeler, J., Vangeli, E., Abdi, Z., O'Gara, C., McRobbie, H., Humphrey, K., Ali, R., et al. (2013) · Addiction · doi:10.1111/add.12304 · Cited by 62
Self-citationManual of Smoking Cessation: A Guide for Counsellors and Practitioners
Peric, T. (2007) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-007-9141-1 · Cited by 60
Hajek, P., Smith, K. M., Dhanji, A.-R., & McRobbie, H. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-140 · Cited by 59
Self-citationUNCERTAINTY OF INCREMENTAL COST-EFFECTIVENESS RATIOS
Severens, J. L., de Boo, T. M., & Konst, E. M. (1999) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462399153157 · Cited by 50
Trials and Tribulations:Emerging Issues in Designing Economic Evaluations Alongside Clinical Trials
Coyle, D., Davies, L. M., & Drummond, M. (1998) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300010588 · Cited by 47
Electronic cigarette use behaviors and motivations among smokers and non-smokers
Sussan, T. E., Shahzad, F. G., Tabassum, E., Cohen, J. E., Wise, R. A., Blaha, M. J., Holbrook, J. T., & Biswal, S. S. (2017) · BMC Public Health · doi:10.1186/s12889-017-4671-3 · Cited by 43 · cited 5×
“Criteria for inclusion in the Health Technology Assessment journal Reports are published in Health Technology Assessment (HTA) if (1) they have resulted from work for the HTA programme, and (2) they are of a sufficiently high scientific quality as assessed by the reviewers and editors.”
BackgroundInfluentialEnglish Stop-Smoking Services: One-Year Outcomes
Bauld, L., Hiscock, R., Dobbie, F., Aveyard, P. N., Coleman, T. J., Leonardi‐Bee, J., McRobbie, H. J., & McEwen, A. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13121175 · Cited by 39 · cited 3×
“Cost of varenicline Number of responders 447 272 286 439 306 317 Mean cost (SD) (£) 4 (24) 2 (12) 4 (25) 2 (17) 1 (15) 3 (19) DOI: 10.”
Self-citationThe Effect of Sensorimotor Replacement on Smoking Cessation and Craving
Przulj, D. (2012) · The Open Addiction Journal · doi:10.2174/1874941001205010041 · Cited by 31 · cited 4×
“Resource Trial arm, mean (SE) (£) NRT (n= 447) E-cigarette (n= 439) Mean cost in the 6 months before baseline Smoking cessation help cost 9 (1) 8 (1) Pharmacotherapy cost 24 (7) 20 (7) Health-care service use cost 612 (108) 512 (62) Cost to the NHS 645 (109) 539 (62) Mean cost in the 6 months post TQD Smoking cessatio…”
BackgroundMethodInfluentialSelf-citationThe Preloading Investigators (2018) · BMJ · doi:10.1136/bmj.k2164 · Cited by 23
Wu, Q., Parrott, S., Godfrey, C., Gilbert, H., Nazareth, I., Leurent, B., Sutton, S., & Morris, R. (2014) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntt136 · Cited by 20
Self-citationMiler, J. A., & Mayer, B. (2016) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.1000290 · Cited by 15 · cited 1×
“5) Inhalator 163 (37) Mouth spray 124 (28) Selecting two NRT products 393 (88) Switched to different NRT product in first 4 weeks 260 (59) a Information is missing for four participants.”
BackgroundThe Health Benefits Of Smoking Cessation: A Report Of The U.S. Surgeon General 1990
Surgeon, U. S. (2012) · Pakistan Heart Journal · Cited by 14
Hájek, P. (2015) · Addiction · doi:10.1111/add.12905 · Cited by 9 · cited 1×
“NRT products used n (%) Type of NRT selected initially N = 442 24-hour patch (21mg) 190 (43) 24-hour patch (14mg) 4 (1) 16-hour patch (25mg) 149 (34) 16-hour patch (15mg) 29 (7) 16-hour patch (10mg) 1 (0.”
(2014) · Institutional Repository University of Antioquia (University of Antioquia) · doi:10.1371/journal.pone
Research works printed but not linked: 7
- Public Health England, 2018, E-cigarettes and Heated Tobacco Products: Evidence Review
- West, 2018, Trends in electronic cigarette use in England. Smoking Toolkit Study
- Curtis, 2016, Unit Costs of Health and Social Care 2016
- NHS Business Services Authority, 2017, PD1 reports
- National Institute for Health and Care Excellence (NICE), 2017, Position Statement on Use of the EQ-5D-5L Valuation Set
- Office for National Statistics (ONS), 2017, Deaths registered in England and Wales: 2016
- Curtis, 2015, Unit Costs of Health and Social Care 2015
Cited by
Electronic cigarettes for smoking cessation
Hartmann-Boyce, J., Lindson, N., Butler, A. R., McRobbie, H., Bullen, C., Begh, R., Theodoulou, A., Notley, C., Rigotti, N. A., Turner, T., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub7 · Cited by 320
Self-citationElectronic cigarettes for smoking cessation
Hartmann-Boyce, J., McRobbie, H., Butler, A. R., Lindson, N., Bullen, C., Begh, R., Theodoulou, A., Notley, C., Rigotti, N. A., Turner, T., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub5 · Cited by 312
Self-citationLe Foll, B., Piper, M. E., Fowler, C. D., Tonstad, S., Bierut, L., Lu, L., Jha, P., & Hall, W. D. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00346-w · Cited by 316
Electronic cigarettes for smoking cessation
Lindson, N., Butler, A. R., McRobbie, H., Bullen, C., Hajek, P., Begh, R., Theodoulou, A., Notley, C., Rigotti, N. A., Turner, T., et al. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub8 · Cited by 170
Self-citationInterventions for Tobacco Cessation in Adults, Including Pregnant Persons
Patnode, C. D., Henderson, J. T., Coppola, E. L., Melnikow, J., Durbin, S., & Thomas, R. G. (2021) · JAMA · doi:10.1001/jama.2020.23541 · Cited by 212
Metadata
- Authors
- Hajek, P., Phillips-Waller, A., Przulj, D., Pesola, F., Smith, K. M., Bisal, N., Li, J., Parrott, S., Sasieni, P., Dawkins, L., Ross, L., Goniewicz, M., Wu, Q., & McRobbie, H. J.
- Affiliations
- Health and Lifestyle Research Unit, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK
- Queen Mary University of London (GB)
- King's College London (GB)
- University of York (GB)
- London South Bank University (GB)
- Leicester City Council (GB)
- Roswell Park Comprehensive Cancer Center (US)
- ORCID
- Venue
- Health Technology Assessment
- Published
- 2019-08
- Volume
- 23
- Issue
- 43
- Pages
- 1-82
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- PMC
- PMC6732716
- OpenAlex
- W2969327526
- Cited by
- 72
- References
- 67
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 8 · 2023: 8 · 2022: 13 · 2021: 14 · 2020: 9 · 2019: 6
- FWCI
- 7.18
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Health Technology Assessment (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, other-oa)
- Research Open (London South Bank University) (acceptedVersion, cc-by-nc)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research Portal (King's College London) (submittedVersion)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- Funders
- Health Technology Assessment programme (12/167/135)
- Cancer Research UK Prevention Trials Unit (A16893)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Keywords
- nicotine replacement therapy, smoking cessation, smoking cessation services, sustained abstinence, behavioral support, cost-efficacy, medication adherence, adverse effects, respiratory health, e-liquids
- MeSH terms
- Adult, Behavior Therapy, Cost-Benefit Analysis, Female, United Kingdom, Humans, Male, Smoking Cessation, Tobacco Use Cessation Devices, Electronic Nicotine Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.